RxDoctor Payments DataLook up a doctor →

CANAKINUMAB_ILARIS_IMMUNOLOGY: payments to doctors

Payments that named CANAKINUMAB_ILARIS_IMMUNOLOGY as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$22K
Providers
4
Transactions
13
Average per transaction
$1,698

The per-transaction average — $1,698 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $5,517, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$22,068100.0%
← All drugs & devices